Searchable abstracts of presentations at key conferences in endocrinology

ea0016s23.4 | Towards a better understanding of hypothalamic–pituitary disorders | ECE2008

Cell cycle control and proliferative diseases of the pituitary

Quereda Victor , Garcia-Lavandeira Montse , Dieguez Carlos , Alvarez Clara , Malumbres Marcos

The importance of cell cycle regulation in pituitary biology has been suggested from the fact that many gene-targeted mouse models of cell cycle mutations develop diverse pituitary pathologies. The retinoblastoma protein (pRb)/cyclin-dependent kinase 4 (Cdk4) pathway, one of the major mitogen-sensor routes in the cell, seems to be critical in the control of pituitary cell proliferation. Both inactivation of pRb or hyperactivation of Cdk4 result in pituitary hyperplasias or tum...

ea0016p131 | Clinical cases | ECE2008

A long standing lymph node metastasis from occult thyroid papillary carcinoma: 10 years evolution until positive diagnosis

Preda Cristina , Stanciu Roxana , Grigorovici Alexandru , Costan Victor , Vulpoi Carmen , Piciu Doina , Zbranca Eusebie

Papillary thyroid carcinoma is a slow growing tumor and is reputed to have an excellent prognosis. In 10–20% of cases, the presence of lymph node metastases led to diagnosis.Objective: To present a patient with enlarged lateral cervical masses, present for 10 years, that proved to be lymph nodes with metastatic thyroid papillary carcinoma.Case report: We report a case of an 26-year-old female patient with 10 years evolution of...

ea0014p77 | (1) | ECE2007

Dialysis therapy and its complications

Bublik Evgeniya , Galstyan Gagik , Melnichenko Galina , Safonov Victor , Shutov Euginy , Filipcev Pavel , Udovichenko Oleg

Aim: To study prevalence of foot complications in patients on dialysis therapy and evaluate the role the haemodynamic changes during dialysis procedure in development of foot problems.Methods: 109 dialysis patients, mean age 49 years. 60 of them had diabetes mellitus (DM): 29 on haemodialysis (HD), 31 on peritoneal dialysis (PD). Non-diabetic patients (NDM): 24 HD, 25 PD.Vascular status: doppler, photoplethysmography. Polyneuropath...

ea0014p410 | (1) | ECE2007

Bone mineral density in end-stage chronic kidney disease patients

Karlovich Natalia , Mokhort Tatiana , Vasiljeva Natalia , Komissarov Kirill , Gromyko Victor , Pilotovich Valery

The usefulness of bone mineral density (BMD) and bone turnover markers measurements to assess the renal osteodystrophy in patients with chronic kidney disease, stage 5 (CKD5) are not well determined.The aim was to analyze BMD, serum levels of parathyroid hormone (PTH) and bone turnover markers in dialysis patients. We examined 45 patients (20 f,25 m; age 45.1±10.8 yrs; age at dialysis onset 40.3±12.3 yrs; dialysis duration 5.0±4.0 yrs). BM...

ea0014p639 | (1) | ECE2007

Screening and treatment of gestational diabetes and impaired glucose tolerance in Georgia

Asatiani Natalia , Kurashvili Ramaz , Dundua Mzia , Shelestova Elena , Tsutskiridze Liana , Hod Moche , Smirnov Sergey , Vlasov Victor

Background and Aim: One of the greatest problem in pregnancy, complicated by diabetes is screening and appropriate care for women, whose diabetes is manifested during pregnancy. The study is aimed at gathering epidemiological data on gestational diabetes mellitus (GDM) and evaluating the of appropriate therapy in this condition.Materials and Methods: Screening for GDM was carried out in – 692 pregnant women. GDM was observed in 3.3% (22 women) and i...

ea0013p106 | Clinical practice/governance and case reports | SFEBES2007

Adult growth hormone replacement using a fixed graded initiation phase followed by an individualised titration phase: a single centre experience

Lecka Agnieszka , Prague Julia , Oguntolu Victor , Miell John , McGregor Alan , Aylwin Simon

Most authorities recognise adult growth hormone deficiency (AGHD) as a distinct endocrine disorder, although determining an appropriate strategy for optimising replacement remains controversial.We reviewed the outcome of a cohort of patients treated with a fixed graded initiation phase followed by an individualised titration phase. Patients were initiated on a starting dose of 0.3 mg recombinant human growth hormone (rhGH) for one month, with increases t...

ea0056p797 | Pituitary - Clinical | ECE2018

Giant prolactinomas in men: clinical features and therapeutic outcomes

Arcano Karina , Jose Diez Juan , Rodriguez Victor , Bernal Carmen , Villabona Carles , Iglesias Pedro

Aims: To evaluate the clinical features and long-term therapeutic outcome of giant prolactinoma (gPRLoma) in men and to compare them with those of a group of male patients with non-gPRL macroprolactinomas (non-gPRLomas).Patients and methods: A retrospective and multicenter study of gPRLomas in men diagnosed in a 20-year period was performed. Clinical data and treatment outcome were registered. The diagnosis of gPRLoma was established when the maximal tum...

ea0092op-02-03 | Oral Session 2: Thyroid hormone action in the brain | ETA2023

Effects of maternal administration of TH-Analog sobetirome and its CNS-Selective prodrug SOB-AM2 in murine MCT8-deficient fetuses

Valcarcel-Hernandez Victor , Guillen Yunta Marina , Scanlan Thomas S. , Barez-Lopez Soledad , Guadano-Ferraz Ana

Inactivating mutations in the thyroid hormones (TH) transporter monocarboxylate transporter 8 (MCT8) lead to the X-linked rare disease named MCT8 deficiency or Allan-Herndon-Dudley Syndrome (AHDS). AHDS pathophysiology is characterized by peripheral hyperthyroidism and cerebral hypothyroidism, which results in severe neurological impairments. Although AHDS leads to a spectrum of severe endocrine and neurological alterations, treatment options for MCT8-deficient patients are li...

ea0099ep735 | Adrenal and Cardiovascular Endocrinology | ECE2024

Heart failure and its reversibility in patients with cushing’s syndrome

Kosharnaia Raisa , Belaya Zhanna , Mamedova Elizaveta , Przhiyalkovskaya Elena , Zuraeva Zamira , Michurova Marina , Kalashnikov Victor

Myopathy is a common complication of Cushing’s syndrome (CS), which predicts the possibility of heart muscle damage and may be a cause of heart failure. Goal of this study is to evaluate the prevalence of heart failure in patients with active CS and the probability of recovery after achieving a remission.Materials and methods: We enrolled patients with CS hospitalized in our clinic from October 2018 to December 2022. To confirm the diagnosis of CS w...

ea0099ep292 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

arGLP-1: our experience in a tertiary hospital in southern spain

Siles-Guerrero Victor , Vilchez-Fernandez Patricia , Santiago-Fernandez Piedad , Lopez-de-la Torre Casares Martin

Objectives: The development of drugs to aid weight loss as an adjunct to dietary and lifestyle recommendations prior to surgical treatment of obesity may help in the management of these patients. To compare the percentage of weight loss among patients who received dietary recommendations (Group 1) and lifestyle recommendations vs those who added arGLP1 semaglutide 1 mg sc (Group 2) or liraglutide 3 mg sc (Group 3) to these recommendations, analysing other variables such as the...